期刊
EXPERT OPINION ON THERAPEUTIC TARGETS
卷 23, 期 8, 页码 695-710出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14728222.2019.1641198
关键词
Notch; heart failure; aortic aneurysm; aortic valve calcification; endothelial dysfunction; cardiotoxicity; macrophages; Dll4; Notch1
资金
- Fondazione Annamaria Sechi per il Cuore
- Fondo Ateneo per la Ricerca
- Russian Science Foundation [18-14-00152]
- Russian Science Foundation [18-14-00152] Funding Source: Russian Science Foundation
Introduction: The Notch pathway is involved in determining cell fate during development and postnatally in continuously renewing tissues, such as the endothelium, the epithelium, and in the stem cells pool. The dysregulation of the Notch pathway is one of the causes of limited response, or resistance, to available cancer treatments and novel therapeutic strategies based on Notch inhibition are being investigated in preclinical and clinical studies in oncology. A large body of evidence now shows that the dysregulation of the Notch pathway is also involved in the pathophysiology of cardiovascular diseases (CVDs).Areas covered: This review discusses the molecular mechanisms involving Notch which underlie heart failure, aortic valve calcification, and aortic aneurysm.Expert opinion: Despite the existence of preventive, pharmacological and surgical interventions approaches, CVDs are the first causes of mortality worldwide. The Notch pathway is becoming increasingly recognized as being involved in heart failure, aortic aneurysm and aortic valve calcification, which are among the most common global causes of mortality due to CVDs. As already shown in cancer, the dissection of the biological processes and molecular mechanisms involving Notch should pave the way for new strategies to prevent and cure these diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据